Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2.

There are now several reports on neurologic features of SARS-CoV-2 infection.1 2 In a recent study of 214 patients with COVID-19, 78 (36.4%) patients had neurological manifestations, including headache, dizziness, acute cerebrovascular diseases, and impaired consciousness.2.